
TENON MEDICAL INC
TNONNASDAQπ #3964 by market capEarnings Aug 13 Β· PostUS Equity
$758.16β² $6.60 (+0.87%)
Simulated price1hβ
24hβ² 0.9%
7dβ
14dβ
30dβ
1yβ
π¦Market Cap
$3M
Small Cap
πRevenue Growth (YoY)
+40.0%
High Growth
πGross Margin
64.8%
High
π΅FCF Margin
β
βοΈP/S Ratio
0.8x
Cheap
Otter Score
58
Weak
No chart data available for TNON.
Trading Snapshot
- Day Range
- $750.34 β $764.76
- 52-Week Range
- $0.28 β $2.48
- Volume
- $5.24B
- Avg Volume
- $5.50B
- Shares Outstanding
- 11.6M
- Next Earnings
- Sep 4, 2026
Fundamentals Snapshot
- Annual Revenue
- $5M
- Last Q Revenue
- $1M
- P/E Ratio
- β
- P/S Ratio
- 0.8x
- EPS (TTM)
- $-1.37
- Dividend Yield
- β
Why Investors Own TNON
- βHigh-growth profile β revenue up +26.6% YoY with expanding US Equity exposure.
- βHealthy economics β 37% gross margin and 13% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
β οΈ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$5Mβ² +32.8% YoY
Gross Margin (TTM)
37.2%β² +1.4% YoY
Operating Income (TTM)
$1Mβ² +32.8% YoY
Free Cash Flow (TTM)
$588,385β² +32.8% YoY
About TENON MEDICAL INC
A company profile for TENON MEDICAL INC isnβt available yet β check back soon.
π¦¦
Otter Score Breakdown
βπQualityβ
β
β
β
β
πGrowthβ
β
β
β
β
βοΈValuationβ
β
β
β
β
β‘Momentumβ
β
β
β
β
Overall Score
Weak
58/100
Analyst Ratings
βConsensus
Buy
8 analysts
Strong Buy2
Buy5
Hold1
Sell0
Strong Sell0
Ratings as of Aug 2026
Latest News & Updates
π
BenzingaΒ·8h ago
Tenon Medical Files Shelf Registration To Offer Securities Up To $100M
-SEC Filing
π°οΈ
BenzingaΒ·22d ago
Tenon Medical Regains Nasdaq Compliance Relating To Maintaining Shareholders' Equity Minimum Of $2.5M
On July 17, 2026, the Company received a notice from Nasdaq that, based on the July 10 8-K (as defined below), the Company had regained compliance with the Stockholders' Equity Rule (as defined below). However, if